Acrylic Acid Methyl Ester

Acrylic Acid Methyl Ester

SCHEMBL3214910

C=CC(=O)OC.C=CC(=O)OCC(CC)CCCC

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.88
CYP3A4 P08684 4/20 0.54
TDP1 Q9NUW8 2/20 0.54
ATM Q13315 1/20 0.54
HPGD P15428 1/20 0.49
ALDH1A1 P00352 5/20 0.48
CA2 P00918 4/20 0.48
RECQL P46063 1/20 0.46
LMNA P02545 3/20 0.44
CA1 P00915 1/20 0.44
MAPK1 P28482 3/20 0.43
HSD17B10 Q99714 1/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP14 P50281 1/20 0.41
ZDHHC7 Q9NXF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Ethyl Ester SCHEMBL18424749 0.96 TSHR (0.81) TSHRCYP3A4TDP1ATMHPGD
Acrylic Acid Methyl Ester SCHEMBL9719491 0.96 TSHR (0.81) TSHRCYP3A4TDP1ATMHPGD
SCHEMBL16765797 0.94 TSHR (1.00) TSHRCYP3A4TDP1ATMHPGD
SCHEMBL14869 0.94 TSHR (1.00) TSHRCYP3A4TDP1ATMHPGD
SCHEMBL29596375 0.94 TSHR (1.00) TSHRCYP3A4TDP1ATMHPGD
SCHEMBL20609794 0.94 TSHR (1.00) TSHRCYP3A4TDP1ATMHPGD
Bromide SCHEMBL20490069 0.92 TSHR (0.97) TSHRCYP3A4TDP1ATMHPGD
Hydrochloric Acid SCHEMBL10432463 0.92 TSHR (0.97) TSHRCYP3A4TDP1ATMHPGD
SCHEMBL31738423 0.92 TSHR (0.97) TSHRCYP3A4TDP1ATMHPGD
Fluoride SCHEMBL28158331 0.92 TSHR (0.97) TSHRCYP3A4TDP1ATMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3236930-B1 DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM AND COSMETIC USE THEREOF OREAL (FR) 2020-02-05 EP claimed
EP-3328349-A1 ANHYDROUS COMPOSITION IN AEROSOL FORM COMPRISING AN ANTIPERSPIRANT ACTIVE AGENT AND A DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM L'OREAL (FR) 2018-06-06 EP claimed
US-20170367966-A1 DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM AND COSMETIC USE THEREOF L'OREAL (FR) 2017-12-28 US claimed
WO-2017017222-A1 ANHYDROUS COMPOSITION IN AEROSOL FORM COMPRISING AN ANTIPERSPIRANT ACTIVE AGENT AND A DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM L'OREAL (FR) 2017-02-02 WO claimed
CN-112689505-B Aqueous patch 日绊株式会社 2024-09-10 CN disclosed
EP-3988172-A1 WATER-BASED ADHESIVE PATCH Teikoku Seiyaku Co., Ltd. (JP) 2022-04-27 EP disclosed
US-20220117934-A1 ROTIGOTINE STABILIZATION METHOD HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2022-04-21 US disclosed
CN-114007594-A Aqueous patch 帝国制药株式会社 2022-02-01 CN disclosed
CN-112689505-A Aqueous patch 日绊株式会社 2021-04-20 CN disclosed
US-10973753-B2 Dispersion of polymer particles in a non-aqueous medium and cosmetic use thereof L'OREAL (FR) 2021-04-13 US disclosed
EP-2601944-B1 TRANSDERMAL PATCH AND METHOD FOR AUGMENTING ADHESIVE STRENGTH THEREOF HISAMITSU PHARMACEUTICAL CO (JP) 2021-02-17 EP disclosed
EP-3328349-A1 ANHYDROUS COMPOSITION IN AEROSOL FORM COMPRISING AN ANTIPERSPIRANT ACTIVE AGENT AND A DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM L'OREAL (FR) 2018-06-06 EP disclosed
EP-2749279-A1 HYDROUS ADHESIVE SKIN PATCH NIPRO Patch Co., Ltd. (JP) 2014-07-02 EP disclosed
CN-203280431-U Three-constituent mixing device and three-constituent mixing binding agent set MITSU CHEMICALS INC 2013-11-13 CN disclosed
EP-2601944-A1 TRANSDERMAL PATCH AND METHOD FOR AUGMENTING ADHESIVE STRENGTH THEREOF Hisamitsu Pharmaceutical Co., Inc. (JP) 2013-06-12 EP disclosed
CN-102083604-A Improved method for degassing cables DOW GLOBAL TECHNOLOGIES INC 2011-06-01 CN disclosed
US-20100047327-A1 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2010-02-25 US disclosed
EP-1847264-A1 PATCH HISAMITSU PHARMACEUTICAL CO. INC. (JP) 2007-10-24 EP disclosed
CN-1235232-C Semiconductor shielding layer composition UNION CARBIDE CHEM PLASTIC (US) 2006-01-04 CN disclosed
CN-1494721-A Semiconductor shielding layer composition ����̼����ѧ�����ϼ�����˾ 2004-05-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047327-A1 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same TLR7, CD69, TLR9 TSHR 1047/4885CYP3A4 2496/4885TDP1 3863/4885
US-10973753-B2 Dispersion of polymer particles in a non-aqueous medium and cosmetic use thereof KRT18, F12, CCNA2 TSHR 3640/4885CYP3A4 2695/4885TDP1 2347/4885
US-20170367966-A1 DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM AND COSMETIC USE THEREOF KRT18, F12, CCNA2 TSHR 3640/4885CYP3A4 2695/4885TDP1 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.